<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Avadel Pharmaceuticals plc

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Avadel Pharmaceuticals plc

    Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and in-licensing / acquiring new products; ultimately, helping patients adhere to their prescribed medical treatment and see better results. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Gregory J. Divis
    • FOUNDED
      1990
    • EMPLOYEES
      101-250
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Ansell Ltd.

    Ansell Ltd.

    Ansell Limited provides health and safety protection solutions. The Company has op...

    Ansell Limited provides health and safety prote...

    Filing Type:    PR
    Hoth Therapeutics, Inc.

    Hoth Therapeutics, Inc.

    Hoth Therapeutics is a development stage biopharmaceutical company focused on prop...

    Hoth Therapeutics is a development stage biopha...

    Filing Type:    PU
    Mirati Therapeutics, Inc.

    Mirati Therapeutics, Inc.

    Mirati Therapeutics (NASDAQ: MRTX) is a San Diego-based clinical-stage biotechnolo...

    Mirati Therapeutics (NASDAQ: MRTX) is a San Die...

    Filing Type:    PU
    Satsuma Pharmaceuticals, Inc.

    Satsuma Pharmaceuticals, Inc.

    With operations in South San Francisco, CA and Research Triangle Park, NC, Satsuma...

    With operations in South San Francisco, CA and ...

    Filing Type:    PU
    ImmunoGen, Inc.

    ImmunoGen, Inc.

    ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to ...

    ImmunoGen is developing the next generation of ...

    Filing Type:    PU
    uniQure N.V.

    uniQure N.V.

    uniQure is delivering on the promise of gene therapy -- single treatments with pot...

    uniQure is delivering on the promise of gene th...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.